Cargando…
The Emerging Role of H3K9me3 as a Potential Therapeutic Target in Acute Myeloid Leukemia
Growing evidence has demonstrated that epigenetic dysregulation is a common pathological feature in human cancer cells. Global alterations in the epigenetic landscape are prevalent in malignant cells across different solid tumors including, prostate cancer, non-small-cell lung cancer, renal cell car...
Autores principales: | Monaghan, Laura, Massett, Matthew E., Bunschoten, Roderick P., Hoose, Alex, Pirvan, Petrisor-Alin, Liskamp, Robert M. J., Jørgensen, Heather G., Huang, Xu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687838/ https://www.ncbi.nlm.nih.gov/pubmed/31428579 http://dx.doi.org/10.3389/fonc.2019.00705 |
Ejemplares similares
-
A KDM4A-PAF1-mediated epigenomic network is essential for acute myeloid leukemia cell self-renewal and survival
por: Massett, Matthew E., et al.
Publicado: (2021) -
Chidamide Enhances the Cytotoxicity of Cytarabine and Sorafenib in Acute Myeloid Leukemia Cells by Modulating H3K9me3 and Autophagy Levels
por: Huang, He, et al.
Publicado: (2019) -
Visfatin and global histone H3K9me levels in colon cancer
por: Al Abdulsalam, Eman A., et al.
Publicado: (2021) -
LukS-PV Induces Apoptosis via the SET8-H4K20me1-PIK3CB Axis in Human Acute Myeloid Leukemia Cells
por: Xu, Liang Fei, et al.
Publicado: (2021) -
The PI3K/AKT Pathway Inhibitor ISC-4 Induces Apoptosis and Inhibits Growth of Leukemia in Preclinical Models of Acute Myeloid Leukemia
por: Annageldiyev, Charyguly, et al.
Publicado: (2020)